Edition:
Deutschland

Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,882JPY
17 Aug 2018
Change (% chg)

-- (--)
Prev Close
¥1,882
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
7,027,719
52-wk High
¥1,887
52-wk Low
¥1,366

4503.T

Chart for 4503.T

About

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive... (more)

Buy/Sell

Sell Hold Buy
2.67 Mean rating from 12 analysts

Overall

Beta: 0.60
Market Cap(Mil.): ¥3,012,207.00
Shares Outstanding(Mil.): 2,068.82
Dividend: 18.00
Yield (%): 2.34

Nikkei ends near 1-month low as trade war concerns sour mood

TOKYO, June 28 Japan's Nikkei ended flat but near one-month lows on Thursday, taking its cue from weakness on Wall Street as a simmering trade row between the United States and China hurt investor risk appetite.

Nikkei hits near 1-month low; large caps weak as trade war fears take toll

TOKYO, June 28 Japanese stocks dropped to near one-month lows on Thursday morning, taking their cue from weakness on Wall Street overnight as the simmering trade row between the United States and China hurt investors' risk appetites.

UPDATE 2-Aquinox to stop development of lead drug; shares plunge

June 27 Aquinox Pharmaceuticals Inc said on Wednesday it planned to stop developing its main drug to treat bladder pain syndrome as it failed to meet the main goal of a late-stage trial, pushing its shares down as much as 85 percent.

Nikkei rises after ECB, looks past BOJ to focus on trade woes

TOKYO, June 15 Japan's Nikkei share average rose on Friday after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled as a brokerage slashed the target price of Tokyo Electron.

Nikkei rises after ECB's decision; chip-related shares tumble

TOKYO, June 15 Japan's Nikkei share average rose on Friday morning after the European Central Bank announced it would avoid raising rates until mid-2019, but chip-related stocks tumbled after a brokerage slashed the target price of Tokyo Electron.

Nikkei rises but gains limited before U.S.-N.Korea summit

TOKYO, June 11 Japanese stocks rose on Monday but gains were limited as investors focused on the U.S.-North Korea summit, while Tokyo Electric soared as the outcome of a local election was seen to be positive for one of the utility's nuclear power plants.

BRIEF- Astellas Pharma signs exclusive licensing agreement with Aquinox Pharmaceuticals

* Says it signed an exclusive license agreement with Aquinox Pharmaceuticals, Inc for Japan and certain other countries in the Asia-Pacific region for Astellas to develop and commercialize rosiptor, Aquinox’s lead drug candidate, a first-in-class, once-daily oral treatment currently in Phase 3 clinical development for interstitial cystitis/bladder pain syndrome (IC/BPS) in North America and Europe

BRIEF-Aquinox And Astellas Announce Exclusive Licensing Agreement For Rosiptor In Asia-Pacific Region Including Japan

* AQUINOX AND ASTELLAS ANNOUNCE EXCLUSIVE LICENSING AGREEMENT FOR ROSIPTOR IN ASIA-PACIFIC REGION INCLUDING JAPAN

BRIEF-FDA Approves Supplemental New Drug Application For Myrbetriq For Treatment Of Overactive Bladder Symptoms

* FDA APPROVES SUPPLEMENTAL NEW DRUG APPLICATION FOR MYRBETRIQ® (MIRABEGRON) FOR USE IN COMBINATION WITH SOLIFENACIN SUCCINATE FOR THE TREATMENT OF OVERACTIVE BLADDER SYMPTOMS

Märkte

  • U.S.
  • Europa
  • Asien
  • Branchen

Branchenüberblick

Energie +0.71%
Rohstoffe +0.72%
Industrie +0.29%
Konjunktur abhängige Waren & Dienstleistungen +0.63%
Konjunktur unabhängige Waren & Dienstleistungen +0.47%
Finanzindustrie +0.51%
Pharma +0.20%
Technologie +0.30%
Telekommunikation +0.40%